Stemirna Competitors and Similar CompaniesClear all
Moderna's competitors and similar companies include CureVac and RNACure.
 Moderna Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine. |  RNACure RNACure is a company that develops a messenger RNA (mRNA) drug discovery platform made from mRNA synthesis. | ||
Founding Date | Founding Date 2010 | Founding Date 2000 | Founding Date 2019 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Shanghai, CN HQ | |
Employees | Employees 5,8004% increase | Employees 82517% decrease | Employees 5 |
Valuation ($) | Valuation ($) 21.2 b | Valuation ($) 648.3 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $1.9b (FY, 2025) | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) N/A |
Cost of goods | Cost of goods $868m (FY, 2025) | Cost of goods €9.7m (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit $1.1b (FY, 2025) | Gross profit €534.4m (FY, 2024) | Gross profit N/A |
Net income | Net income ($2.8b) (FY, 2025) | Net income €162.2m (FY, 2024) | Net income N/A |
Operating ⚠ | |||
Patent Applications | Patent Applications 430 (FY, 2021) | Patent Applications 500 (Mar, 2020) | Patent Applications N/A |
Patents Issued | Patents Issued 270 (FY, 2020) | Patents Issued 233 (May, 2020) | Patents Issued N/A |
Funding | |||
Total funding raised | Total funding raised $ 1.8b | Total funding raised $ 1.1b | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
CureVac
HQ
Tübingen, DE
Employees
825↓ 17% decrease
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View companyRNACure
HQ
Shanghai, CN
Employees
5
RNACure is a company that develops a messenger RNA (mRNA) drug discovery platform made from mRNA synthesis.
View company